通过专为投资者打造的一站式数据看板，全面查看 BridgeBio Pharma Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图，助您更轻松地进行财务分析。您可以查看最新年度财务报告，也可以通过利润表、资产负债表和现金流量表，按季度分析公司表现。借助实时财务指标，持续追踪公司的经营状况和市场表现更加便捷。

关键财务比率

总市值

13.01B

股息TTM

0.00

市盈率 TTM

-17.78

每股收益TTM

-3.75

营业收入

502.08M

净利润

-535.76M

净资产收益率

0.00%

总资产收益率

-64.80%

BridgeBio Pharma Inc 财报日历

财务报表摘要

单季报

单季报+年报

单季报

年报

YOY

隐藏空白行

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

财务指标

每股收益

18.57%-0.78

4.36%-0.84

28.78%-1.00

-10.81%-0.95

-143.83%-0.95

-346.82%-0.88

-45.17%-1.40

20.69%-0.86

60.19%-0.39

78.54%-0.20

-4.61%-0.96

---1.08

---0.98

---0.92

---2.34

----

营业收入

120.39%243.68M

66.78%194.51M

2521.18%154.18M

4318.01%120.70M

4999.86%110.56M

-44.76%116.63M

237.08%5.88M

-33.22%2.73M

32.11%2.17M

11461.88%211.12M

-6.68%1.75M

1110.36%4.09M

-97.77%1.64M

7.79%1.83M

-85.49%1.87M

-85.58%338.00K

36.51%73.75M

266.67%1.69M

10462.30%12.89M

-71.16%2.34M

净利润

16.32%-152.22M

2.02%-164.04M

27.24%-192.86M

-12.78%-182.74M

-147.64%-181.90M

-375.41%-167.42M

-57.63%-265.05M

8.45%-162.04M

53.48%-73.46M

74.87%-35.22M

-22.21%-168.15M

-28.88%-177.00M

-1502.06%-157.90M

28.64%-140.16M

6.51%-137.59M

11.93%-137.34M

89.77%-9.86M

-20.43%-196.40M

-22.67%-147.18M

-34.59%-155.94M

利润率

61.51%-63.97%

41.12%-85.63%

97.22%-126.24%

97.45%-153.22%

95.23%-166.20%

-749.04%-145.42%

53.43%-4545.89%

-37.03%-6012.23%

64.42%-3484.50%

99.78%-17.13%

-29.85%-9760.92%

---4387.39%

---9792.99%

---7816.65%

---7517.11%

---454.07%

----

毛利率

-2.97%93.83%

-2.91%94.89%

46.73%94.74%

21.06%94.56%

33.53%96.70%

-1.99%97.74%

-1.77%64.57%

-8.52%78.11%

14.05%72.42%

54.96%99.72%

0.50%65.73%

--85.38%

--63.50%

--64.35%

--65.40%

--96.32%

----

资产负债率

11.77%275.60%

-8.29%243.97%

20.85%289.26%

4.11%269.19%

14.04%246.58%

31.68%266.03%

-24.26%239.35%

-1.60%258.55%

-36.65%216.22%

-26.22%202.03%

15.31%316.03%

--262.76%

--341.29%

--273.83%

--274.08%

--233.10%

----

利润表

营业收入

120.39%243.68M

66.78%194.51M

2521.18%154.18M

4318.01%120.70M

4999.86%110.56M

-44.76%116.63M

237.08%5.88M

-33.22%2.73M

32.11%2.17M

11461.88%211.12M

-6.68%1.75M

1110.36%4.09M

-97.77%1.64M

7.79%1.83M

-85.49%1.87M

-85.58%338.00K

36.51%73.75M

266.67%1.69M

10462.30%12.89M

-71.16%2.34M

营业利润

19.77%-107.08M

-2.08%-105.96M

41.97%-128.43M

27.13%-136.36M

22.69%-133.47M

-2873.23%-103.80M

-25.29%-221.33M

-18.87%-187.13M

-21.10%-172.65M

103.05%3.74M

-45.35%-176.66M

-26.85%-157.42M

-98.62%-142.57M

18.69%-122.79M

26.61%-121.54M

16.99%-124.10M

23.65%-71.78M

9.84%-151.02M

-29.90%-165.61M

-24.65%-149.50M

净利润

16.32%-152.22M

2.02%-164.04M

27.24%-192.86M

-12.78%-182.74M

-147.64%-181.90M

-375.41%-167.42M

-57.63%-265.05M

8.45%-162.04M

53.48%-73.46M

74.87%-35.22M

-22.21%-168.15M

-28.88%-177.00M

-1502.06%-157.90M

28.64%-140.16M

6.51%-137.59M

11.93%-137.34M

89.77%-9.86M

-20.43%-196.40M

-22.67%-147.18M

-34.59%-155.94M

资产负债表

流动资产

19.83%1.09B

78.56%1.24B

10.69%797.75M

88.80%839.38M

48.04%912.28M

-11.26%695.17M

50.90%720.69M

-24.35%444.58M

42.36%616.24M

41.74%783.42M

-12.98%477.59M

-8.49%587.67M

-43.87%432.88M

-22.83%552.70M

-38.25%548.85M

0.39%642.22M

-15.23%771.28M

-24.22%716.23M

38.27%888.86M

-14.18%639.71M

流动负债总额

406.47%890.65M

436.72%816.37M

86.51%287.97M

55.59%216.60M

30.88%175.85M

7.51%152.10M

7.34%154.40M

31.26%139.22M

22.02%134.36M

46.46%141.48M

18.46%143.84M

-11.01%106.06M

-21.99%110.12M

-6.64%96.60M

-10.10%121.43M

24.39%119.19M

7.01%141.16M

9.22%103.46M

41.21%135.07M

26.57%95.82M

总资产

12.69%1.22B

55.50%1.37B

1.82%936.02M

50.12%998.25M

35.98%1.08B

3.80%881.64M

68.26%919.34M

1.52%664.98M

57.72%794.38M

35.75%849.33M

-12.30%546.38M

-10.12%655.01M

-41.59%503.66M

-23.05%625.68M

-38.48%623.04M

-6.75%728.74M

-20.27%862.23M

-25.62%813.15M

43.95%1.01B

-0.78%781.52M

总负债

30.24%3.72B

44.42%3.64B

26.74%3.01B

55.09%2.92B

52.34%2.86B

33.62%2.52B

25.84%2.38B

1.87%1.88B

1.25%1.88B

2.55%1.89B

1.12%1.89B

-0.56%1.85B

-1.28%1.85B

-0.78%1.84B

-0.55%1.87B

22.52%1.86B

22.13%1.88B

25.14%1.85B

215.32%1.88B

166.53%1.52B

总权益

-40.91%-2.51B

-38.46%-2.27B

-42.46%-2.08B

-57.81%-1.92B

-64.35%-1.78B

-58.04%-1.64B

-8.57%-1.46B

-2.07%-1.22B

19.82%-1.08B

14.56%-1.04B

-7.84%-1.34B

-5.61%-1.19B

-32.97%-1.35B

-16.62%-1.21B

-43.83%-1.24B

-53.61%-1.13B

-122.77%-1.02B

-168.15%-1.04B

-902.31%-865.58M

-436.96%-735.87M

现金流量表

经营净额

11.87%-71.10M

0.98%-197.28M

71.11%-56.42M

39.32%-109.57M

-208.00%-80.68M

9.25%-199.24M

-56.49%-195.33M

-24.33%-180.57M

165.90%74.70M

-52.12%-219.54M

-33.86%-124.82M

-7.45%-145.23M

-272.22%-113.35M

10.16%-144.32M

30.36%-93.24M

-11.19%-135.16M

66.80%-30.45M

-6.55%-160.63M

-39.10%-133.90M

7.69%-121.56M

投资净额

237.56%17.89M

-2579.31%-42.73M

-343.44%-14.35M

-88.32%4.46M

-527.84%-13.00M

-107.01%-1.59M

-4804.55%-3.24M

1.44%38.23M

-26.22%3.04M

85.01%22.75M

-100.37%-66.00K

-74.34%37.68M

-97.25%4.12M

-91.13%12.30M

-17.59%17.96M

149.05%146.86M

32586.03%149.70M

149.15%138.62M

-73.74%21.80M

230.89%58.97M

融资净额

-149.25%-148.77M

811.50%549.89M

-100.46%-2.18M

-226.45%-894.00K

5372.14%302.04M

-78.42%60.33M

10578.24%473.93M

-99.77%707.00K

-365.39%-5.73M

86.06%279.55M

-170.93%-4.52M

21148.44%307.04M

94.08%-1.23M

94005.63%150.25M

-98.04%6.38M

101.07%1.45M

-1395.04%-20.80M

-100.03%-160.00K

7081.22%325.38M

-4969.02%-135.46M

营业收入

业务

报告期:

暂无数据

地区

报告期:

暂无数据

常见问题

BridgeBio Pharma Inc的总收入是多少？



根据BridgeBio Pharma Inc的FY2025财报，总收入达到了502.08M（同比变化221.90M）。

BridgeBio Pharma Inc的流动资产是多少？



根据BridgeBio Pharma Inc的FY2025财报，流动资产为797.75M（同比变化10.69）。

BridgeBio Pharma Inc的总资产是多少？



根据BridgeBio Pharma Inc的FY2025财报，BridgeBio Pharma Inc的总资产为936.02M（同比变化1.82）。

BridgeBio Pharma Inc的总负债是多少？



根据BridgeBio Pharma Inc的FY2025财报，BridgeBio Pharma Inc的总负债为3.01B（同比变化26.74）。

BridgeBio Pharma Inc的总权益是多少？



根据BridgeBio Pharma Inc的FY2025财报，BridgeBio Pharma Inc的总权益为-2.08B（同比变化-42.46）。

BridgeBio Pharma Inc的净营业收入是多少？



根据BridgeBio Pharma Inc的FY2025财报，BridgeBio Pharma Inc的净营业收入为-502.06M（同比变化13.04）。

BridgeBio Pharma Inc的净投资是多少？



根据BridgeBio Pharma Inc的FY2025财报，BridgeBio Pharma Inc的净投资为-24.49M（同比变化-140.29）。

BridgeBio Pharma Inc的净融资是多少？



根据BridgeBio Pharma Inc的FY2025财报，BridgeBio Pharma Inc的净融资为359.29M（同比变化-52.00）。

BridgeBio Pharma Inc的每股收益（EPS）是多少？



根据BridgeBio Pharma Inc的FY2025财报，每股收益（EPS）为-3.79（同比变化-31.46）。

BridgeBio Pharma Inc的净利润是多少？



根据BridgeBio Pharma Inc的FY2025财报，净利润为-724.93M（同比变化-35.31）。

BridgeBio Pharma Inc的净利润率是多少？



根据BridgeBio Pharma Inc的FY2025财报，净利润率为-145.98（同比变化40.38）。

BridgeBio Pharma Inc的毛利率是多少？



根据BridgeBio Pharma Inc的FY2025财报，毛利率为95.82（同比变化-2.47）。

BridgeBio Pharma Inc的债务与资产比率是多少？



根据BridgeBio Pharma Inc的FY2025财报，债务与资产比率为289.26（同比变化20.85）。

BridgeBio Pharma Inc的资产回报率（ROA）是多少？



根据BridgeBio Pharma Inc的FY2025财报，资产回报率（ROA）为-79.01（同比变化-6.56）。

BridgeBio Pharma Inc的营业利润是多少？



根据BridgeBio Pharma Inc的FY2025财报，营业利润为-502.06M（同比变化13.04）。